CDSCO mandates application process for license of r-DNA products to be only through ONDLS portal: Gireesh Babu, New Delhi ...
BDCDA informs Karnataka FDA about practical challenges in implementing geo-tagging application: Nandita Vijayasimha, ...
Heartfulness survey finds heavy AI users with high screen exposure reporting later bedtimes and rising daytime fatigue: Our Bureau, Bengaluru Friday, March 13, 2026, 17:15 Hrs [IS ...
Amydis receives phase 2 NIH grant award of $2.5 million to advance a novel approach to detect biomarker TDP-43: San Diego Friday, March 13, 2026, 18:00 Hrs [IST] Amydis Inc., a pr ...
The US Food and Drug Administration (FDA) launched a new unified platform for analyzing adverse event reports. This platform — called the FDA Adverse Event Monitoring System (AEMS) — represents a ...
Citius Oncology reports positive results from phase 1 study of Lymphir in combo with pembrolizumab in relapsed or refractory gynaecologic cancers: Cranford, New Jersey Friday, Mar ...
Pharma exports to the GCC countries & WANA region affected badly by US-Israel-Iran conflict: Experts
Pharma exports to the GCC countries & WANA region affected badly by US-Israel-Iran conflict: Experts: Shardul Nautiyal, Mumbai Friday, March 13, 2026, 08:00 Hrs [IST] Pharma expor ...
Breckenridge Pharma partners with Maiva Pharma to supply sterile injectables to hospitals and clinics in US: New Jersey Friday, March 13, 2026, 13:00 Hrs [IST] Breckenridge Pharma ...
The Institute of Teaching and Research in Ayurveda (ITRA) recently concluded ‘Rasameemamsa-2026’, a landmark national conference at Jamnagar in Gujarat that culminated in the historic adoption of the ...
MetaVia expands global patent protection for vanoglipel, supporting metabolic and liver disease therapy through 2035: Cambridge, Massachusetts Friday, March 13, 2026, 17:00 Hrs [I ...
VLCC becomes the first wellness brand to get Indian Medical Association recommendation for weight management & metabolic wellness: Our Bureau, Bengaluru Friday, March 13, 2026, 11 ...
Shilpa Biologicals and mAbTree Biologics secure US FDA orphan drug designation for breakthrough biologics to treat rare blood cancers: Our Bureau, Bengaluru Friday, March 13, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results